Skip to content
Search

Latest Stories

Pharmacy is under severe strain, time for the government to back those who put patients first

The Government must fund the pharmacy sector sufficiently to secure it’s future.
Currently, the number of pharmacies operating in England is at an almost twenty year low. (gettyimages)

"The new contract in England has to provide the injection of cash the pharmacy sector desperately requires" 

By Jeremy Meader

Healthcare is one of the most crucial sectors in the UK accounting for over £290 billion, around 10% of the GDP for the entire country.

Despite this, however, many businesses operating in the healthcare sector are currently in favour of an urgent cash injection from the government. The figures make for sobering reading with over 65% of pharmacies operating at a loss and a bleak forecast that one in six might shut their doors for good within the next year.


Business costs have soared in the last two years and combined with a funding cut of around 30% in real terms over the last decade this has left many pharmacies struggling to make ends meet.

In real terms, these issues affect those who we wish to help the most - our patients.

As the expenditure rises, income doesn’t always follow meaning that pharmacy staff have to work even harder. However, despite their best efforts they report that this has an impact on some of the valuable face time that they can give to their patients.

Longer prescription dispensing times have been an issue across the board as this then creates a domino effect on responding to patient enquiries. This then means that when a patient is actually in store there is less time for a pharmacist to spend with a patient discussing their health issues.

A majority of pharmacies in the UK rely heavily on NHS funding to account for 90% plus of income to the store. As mentioned above, that figure has been steadily cut in real terms by around 30% despite an expectation of more public services being provided.

Pharmacy owners are experiencing sleepless nights worrying about how to best try to continue operating despite the threats to their business. Many admit that they consistently face making hard decisions weighing up their personal feelings against a balance sheet.

Pharmacists across the country who operate their stores have admitted to overstaffing at times to try and redress situations with patients. However, when they talk to me, they concede that this won’t be possible forever unless there is some financial help offered by Keir Starmer’s government to the health sector. Healthcare workers and particularly those in pharmacies concede they are feeling burnt out and have done for months.

The lack of true reimbursement has prevented pharmacists from fully being able to thrive in their jobs as they wrestle with their conscience over dispensing medicine at a loss.

Currently, the number of pharmacies operating in England is at an almost twenty year low and looks set to fall rather than rise unless Sir Keir’s Government acts quickly to inject some much-needed cash into the sector.

Pharmacies were on the front line during extraordinary times including the two-year pandemic of Covid-19, it is time now for the prime minister to offer his support to ensure that the pharmacy sector doesn’t disintegrate in the next decade.

In particular, I would like to see the government and NHS offer their help not only financially but by listening to those in the sector who know it best. It would be welcomed if the Labour party invested in the future of community pharmacy as well as offering short term relief to allow for pharmacies to get back on an even keel.

A pharmacy is the cornerstone of society in many towns across the UK and both those working in the sector and our patients want us to be around for generations to come.

It is vital that the Government ensures this is the case as pharmacies offer tandem support with so many other areas of healthcare through a variety of programmes including Pharmacy First.

The new contract in England has to provide the injection of cash the sector desperately requires. Pharmacy has always put patients first. The Government and NHS must recognise this and fund the sector sufficiently to secure it’s future. Ultimately it is patients who will suffer most if this doesn’t happen.

Jeremy Meader Chief Wholesale Officer Bestway Healthcare

Jeremy Meader is the Chief Wholesale Officer of Bestway Healthcare, overseeing brands such as Lexon, Wardles, and Bestway Medhub. Jeremy has over 25 years of experience in the UK pharmaceutical sector, and has worked in executive roles across the industry.

More For You

Why community pharmacy must embrace private services
The range of private services offered by pharmacists is likely to grow exponentially over the coming years (gettyimages)

Future of community pharmacy: Be more private

Tariq Muhammad considers how community pharmacy must explore private services to help create a more sustainable future.

We know remuneration influences behaviour. If I have a construction company and I pay a bricklayer a fee per brick to supply and fit, I suspect he will source them from the cheapest supplier and lay as many bricks as he possibly can. If one day, I reduce the fee such that it barely covers the cost of the brick, at a time when bricks are in short supply and labour costs have gone up, oh and I take some money off him for the profit he made on bricks he supplied the previous year, I suspect he will tell me to stick my job where the sun doesn’t shine.

It may be a crude analogy, but it is pretty much what’s happened in community pharmacy over the last 20 years. The remuneration we get for dispensing does not cover the cost of providing the service. The reimbursement for the drugs does not cover the cost of the drugs. In fact, we make a loss on many items given all the clawbacks and supply shortages. Wages have gone up. And then each year the government claws back profit they say we’ve made, apparently!

Keep ReadingShow less
Harry McQuillan reflects on his first year as chairman of Numark UK
Harry McQuillan, Numark UK Chairman

Reflections on my first year as Numark UK chairman

The lack of a stable, predictable funding framework remains a critical issue for pharmacies in England - Harry McQuillan

As I reflect on my first year as chairman of Numark, I am struck by the incredible progress we’ve made together and the exciting opportunities that lie ahead for community pharmacy. This milestone feels like the perfect moment to take stock of our achievements and look forward to the future.

Stepping into this role after 17 years as a chief executive was both exhilarating and, I’ll admit, a little daunting. However, any initial apprehension quickly faded thanks to the warm welcome and support from my fellow UK Board members, the exceptional Numark team, and our dedicated members. It’s this shared sense of purpose, supporting our members to deliver outstanding care to their communities that continues to inspire me every day.

Keep ReadingShow less
collaboration in healthcare settings
collaboration in healthcare settings

Do you have to like each other to Collaborate?

By Trevor Gore, Associate Director, Institute for Collaborative Working (ICW)

May I be one of the last people to wish you a ‘Happy New Year’

The new year is traditionally a time to reflect on the year past and look forward to the new year and all the joys and challenges it will bring, possibly by making a resolution. However, the statistics do not bode well for your resolution lasting.

Keep ReadingShow less
Ministers must now urgently table the long trailed new deal for community pharmacy
Paul Rees Former NPA chief executive

Community pharmacy owners are ‘fed up’ with how they’re treated by the NHS

"Ministers must now urgently table the long trailed new deal for community pharmacy"

By Paul Rees, former chief executive of the National Pharmacy Association (NPA)

When former Health Secretary Matt Hancock gave evidence to the Covid public inquiry he let the cat out of the bag.

Keep ReadingShow less
Category M price list for January 2025
gettyimages

Impact of Category M price changes in January 2025

Pharmacies face £1,100 monthly reimbursement cuts as government implements £34 million adjustment to Category M prices

The government have imposed a £34 million per quarter adjustment to the prices of Category M* products in the English Drug Tariff from January 2025. They say that this is to compensate for retained margin adjustment following the latest margin survey, changes in the current market prices of medicines, and the addition of new lines into this category.

Keep ReadingShow less